Muller WJ - Search Results

1

HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.

Reilly RT, Gottlieb MB, Ercolini AM, Machiels JP, Kane CE, Okoye FI, Muller WJ, Dixon KH, Jaffee EM. Reilly RT, et al. Among authors: muller wj. Cancer Res. 2000 Jul 1;60(13):3569-76. Cancer Res. 2000. PMID: 10910070

2

Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice.

Lollini PL, Nicoletti G, Landuzzi L, De Giovanni C, Rossi I, Di Carlo E, Musiani P, Muller WJ, Nanni P. Lollini PL, et al. Among authors: muller wj. Int J Cancer. 1998 Sep 11;77(6):937-41. doi: 10.1002/(sici)1097-0215(19980911)77:6<937::aid-ijc24>3.0.co;2-x. Int J Cancer. 1998. PMID: 9714068

3

Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: an animal model for CEA-directed tumor immunotherapy.

Thompson JA, Eades-Perner AM, Ditter M, Muller WJ, Zimmermann W. Thompson JA, et al. Among authors: muller wj. Int J Cancer. 1997 Jul 3;72(1):197-202. doi: 10.1002/(sici)1097-0215(19970703)72:1<197::aid-ijc28>3.0.co;2-f. Int J Cancer. 1997. PMID: 9212243

4

Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression.

Lifsted T, Le Voyer T, Williams M, Muller W, Klein-Szanto A, Buetow KH, Hunter KW. Lifsted T, et al. Int J Cancer. 1998 Aug 12;77(4):640-4. doi: 10.1002/(sici)1097-0215(19980812)77:4<640::aid-ijc26>3.0.co;2-8. Int J Cancer. 1998. PMID: 9679770

5

Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4.

Jackson-Fisher AJ, Bellinger G, Shum E, Duong JK, Perkins AS, Gassmann M, Muller W, Kent Lloyd KC, Stern DF. Jackson-Fisher AJ, et al. Oncogene. 2006 Sep 14;25(41):5664-72. doi: 10.1038/sj.onc.1209574. Epub 2006 May 1. Oncogene. 2006. PMID: 16652155

6

Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice.

Kenney NJ, Smith GH, Maroulakou IG, Green JH, Muller WJ, Callahan R, Salomon DS, Dickson RB. Kenney NJ, et al. Among authors: muller wj. Mol Carcinog. 1996 Jan;15(1):44-56. doi: 10.1002/(SICI)1098-2744(199601)15:1<44::AID-MC7>3.0.CO;2-S. Mol Carcinog. 1996. PMID: 8561865

7

Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer.

Talts JF, Wirl G, Dictor M, Muller WJ, Fässler R. Talts JF, et al. Among authors: muller wj. J Cell Sci. 1999 Jun;112 ( Pt 12):1855-64. doi: 10.1242/jcs.112.12.1855. J Cell Sci. 1999. PMID: 10341205

8

Suppression of tumor growth and metastasis in Mgat5-deficient mice.

Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, Dennis JW. Granovsky M, et al. Among authors: muller wj. Nat Med. 2000 Mar;6(3):306-12. doi: 10.1038/73163. Nat Med. 2000. PMID: 10700233

9

Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression.

Kupferman ME, Fini ME, Muller WJ, Weber R, Cheng Y, Muschel RJ. Kupferman ME, et al. Among authors: muller wj. Am J Pathol. 2000 Dec;157(6):1777-83. doi: 10.1016/S0002-9440(10)64815-8. Am J Pathol. 2000. PMID: 11106549 Free PMC article.

10

Functional analysis of mouse keratin 8 in polyoma middle T-induced mammary gland tumours.

Baribault H, Wilson-Heiner M, Muller W, Penner J, Bakhiet N. Baribault H, et al. Transgenic Res. 1997 Nov;6(6):359-67. doi: 10.1023/a:1018427215923. Transgenic Res. 1997. PMID: 9423286

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

386 results

Search Page

Filters